Castle Biosciences shares up 40c or +1.48% to $27.46 per share in after-hours trading after announcing the company will share new data supporting the clinical value of Castle’s skin cancer test portfolio at the 2023 Winter Clinical Dermatology Conference – Hawaii , being held Jan. 13-18 in Kohala Coast, Hawaii.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CSTL: